期刊文献+

老年HFpEF患者QRS-T夹角的意义

Significance of QRS-T angle in elderly patients with heart failure with preserved ejection fraction
原文传递
导出
摘要 目的观察老年射血分数保留心力衰竭(HFp EF)患者的心电图平面QRS-T夹角与心功能NYHA分级及预后的关系。方法选取老年HFp EF患者204例,按照NYHA心功能分级标准分为3组:心功能Ⅱ级组(n=64)、Ⅲ级组(n=85)、Ⅳ级组(n=55)。同期选取心功能正常患者74例作为对照组。所有患者于入院时行心电图检查记录平面QRS-T夹角并随访1年。结果 HFp EF组QRS-T夹角(87.48°±23.25°)、血浆BNP水平(348.4±169.03pg/ml)以及发生预后不良比例(36.8%)高于对照组(38.95°±16.89°、58.35±17.52pg/ml、8.1%,p<0.05),随NYHA心功能分级增加,QRS-T夹角和血浆BNP水平逐渐升高(p<0.05)。预后不良患者QRS-T夹角、血浆BNP水平高于预后良好患者(p<0.05)。结论老年HFp EF患者的QRS-T夹角与心功能NYHA分级及预后密切相关。通过心电图检测平面QRS-T夹角可以用于辅助诊断HFp EF并判断其心力衰竭的严重程度以及评估预后。 Objective To observe the relationship between plane QRS-T angle and NYHA cardiac function and prognosis in elderly patients with heart failure with preserved ejection fraction(HFp EF). Methods A total of 204 elderly patients with HFp EF was divided into three groups according to the NYHA cardiac function classification standard(64 with NYHA class Ⅱ, 85 with NYHA class Ⅲ, 55 with NYHA class Ⅳ) and 74 with normal cardiac function were enrolled in control group. Plane QRS-T angle was detected with routine electrocardiogram on admission for every subject. Results The QRS-T angle(87.48°±23.25°), BNP(348.4±169.03 pg/ml) and the incidence of poor prognosis(36.8%) in HFp EF group was significantly larger than those in control group(38.95°±16.89°,58.35±17.52 pg/ml, 8.1%, p<0.05). The QRS-T angle and the level of BNP increased gradually with the increase of cardiac function grade(p<0.05). The QRS-T angle and BNP in poor prognosis group was larger than those in good prognosis group(p<0.05). Conclusions QRS-T angle of elderly HFp EF patients has a close relationship with NYHA cardiac function and prognosis. Plane QRS-T angle can be used to assist in the diagnosis of HFp EF and the determination of the severity and prognosis of heart failure.
作者 李琳 齐惠英 Li lin;Qi huiying(Department of Cardiology,The Third Central Hospital of Tianjin,Tianjin,300250,China)
出处 《临床心电学杂志》 2021年第5期345-348,共4页 Journal of Clinical Electrocardiology
关键词 射血分数保留心力衰竭 QRS-T夹角 心功能 预后 Heart failure with preserved ejection fraction QRS-T angle Cardiac function Prognosis
  • 相关文献

参考文献4

二级参考文献53

  • 1Yancy CW,Jessup M,Bozkurt B,et al.2013 ACCF/AHA guideline for the management of heart failure:a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines[J].J Am Coll Cardiol,2013,62:e147-e239.
  • 2Bui AL,Horwich TB,Fonarow GC.Epidemiology and risk profile of heart failure.Nat Rev Cardiol,2011,8:30-41.
  • 3Bmuwers FP,de Boer RA,van der Harst P,et al.Incidence and epidemiology of new onset heart failure with preserved vs.reduced ejection fraction in a community-based cohort:11-year follow-up of PREVEND.Eur Heart J,2013,34:1424-1431.
  • 4Steinberg BA,Zhao X,Heidenreich PA,et al.Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction:prevalence,therapies,and outcomes.Circulation,2012,126:65-75.
  • 5Butler J,Fonarow GC,Zile MR,et al.Developing therapies for heart failure with preserved ejection fraction:current state and future directions.JACC Heart fail,2014,2:97-112.
  • 6Bhatia RS,Tu JV,Lee DS,et al.Outcome of heart failure with preserved ejection fraction in a population-based study.N Engl J Med,2006,355:260-269.
  • 7Farr MJ,Lang CC,Lamanca JJ,et al.Cardiopulmonary exercise variables in diastolic versus systolic heart failure.Am J Cardiol,2008,102:203-206.
  • 8McMurray JJ,Adamopoulos S,Anker SD,et al.ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012:The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012of the European Society of Cardiology.Developed in collaboration with the Heart Failure Association(HFA)of the ESC.Eur J Heart Fail,2012,14:803-869.
  • 9DjousséL,Kurth T,Gaziano JM.Cystatin C and risk of heart failure in the Physicians'Health Study(PHS).Am Heart J,2008,155:82-86.
  • 10O'Meara E,Clayton T,McEntegart MB,et al.Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure:results of the Candesartan in Heart Failure:Assessment of Reduction in Mortality and Morbidity(CHARM)Program.Circulation,2006,113:986-994.

共引文献59

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部